Charles Schwab Investment Management Inc Nurix Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 511,720 shares of NRIX stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

511,720

Previous 623,404 17.92%

Holding current value

$11.3 Million

Previous $13 Million 11.7%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$18.93 - $25.69 $2.11 Million - $2.87 Million	-111,684 Reduced 17.92%	511,720 $11.5 Million
Q2 2024 Aug 12, 2024	SELL	$12.02 - $21.3 $225,807 - $400,141	-18,786 Reduced 2.93%	623,404 $13 Million
Q1 2024 May 08, 2024	BUY	$7.77 - $15.66 $154,568 - $311,524	19,893 Added 3.2%	642,190 $9.44 Million
Q4 2023 Feb 06, 2024	BUY	$4.25 - $10.71 $228,314 - $575,351	53,721 Added 9.45%	622,297 $6.42 Million
Q3 2023 Nov 08, 2023	BUY	$7.86 - $10.08 $1.45 Million - $1.86 Million	184,617 Added 48.08%	568,576 $4.47 Million
Q2 2023 Aug 09, 2023	SELL	$8.7 - $13.28 $7,664 - $11,699	-881 Reduced 0.23%	383,959 $3.84 Million
Q1 2023 May 11, 2023	BUY	$8.56 - $13.26 $16,478 - $25,525	1,925 Added 0.5%	384,840 $3.42 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $82,252 - $121,709	8,342 Added 2.23%	382,915 $4.2 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $1.04 Million - $1.67 Million	84,114 Added 28.96%	374,573 $4.88 Million
Q2 2022 Aug 15, 2022	BUY	$7.88 - $14.82 $160,783 - $302,387	20,404 Added 7.56%	290,459 $3.68 Million
Q1 2022 May 13, 2022	BUY	$12.94 - $29.65 $83,010 - $190,204	6,415 Added 2.43%	270,055 $3.78 Million
Q4 2021 Feb 11, 2022	BUY	$26.43 - $34.5 $102,548 - $133,860	3,880 Added 1.49%	263,640 $7.63 Million
Q3 2021 Nov 16, 2021	BUY	$22.71 - $36.69 $2.95 Million - $4.77 Million	129,872 Added 99.99%	259,760 $7.78 Million
Q2 2021 Aug 16, 2021	BUY	$24.21 - $35.89 $410,432 - $608,443	16,953 Added 15.01%	129,888 $3.45 Million
Q1 2021 May 17, 2021	BUY	$26.98 - $50.17 $973,006 - $1.81 Million	36,064 Added 46.91%	112,935 $3.51 Million
Q4 2020 Feb 16, 2021	BUY	$22.85 - $48.44 $106,526 - $225,827	4,662 Added 6.46%	76,871 $2.53 Million
Q3 2020 Nov 13, 2020	BUY	$16.05 - $34.91 $1.16 Million - $2.52 Million	72,209 New	72,209 $2.52 Million

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $1.04B
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Nurix Therapeutics, Inc. Transaction History